Download PDF
Exp Clin Endocrinol Diabetes 2005; 113(3): 171-175
DOI: 10.1055/s-2005-837519
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Acute Hyperinsulinemia is Associated with Increased Plasma Adrenomedullin Concentrations in Uncomplicated Obesity

C. Letizia1 , G. Iacobellis2 , C. Caliumi1 , F. Leonetti2 , D. Cotesta1 , M. C. Ribaudo2 , L. Petramala1 , R. Cianci1 , M. Celi1 , E. D'Erasmo1 , U. Di Mario2
  • 1Internal Medicine, Department of Clinical Science, University of Rome “La Sapienza”, Rome, Italy
  • 2Endocrinology, Department of Clinical Science, University of Rome “La Sapienza”, Rome, Italy
Further Information

Publication History

Received: January 22, 2004 First decision: May 6, 2004

Accepted: September 9, 2004

Publication Date:
23 March 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Objective: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported.

Purpose: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity.

Research Methods: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 ± 9.8 kg/m2), 21 females and 2 males (mean age 31 ± 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 ± 12 years; BMI 23.3 ± 3.2 kg/m2).

Results: Baseline plasma AM was found to be higher in obese subjects (20.4 ± 8.4 pg/ml) than in normal subjects (11.3 ± 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 ± 8.4 pg/ml at 0 min to 26 ± 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp.

Discussion: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.

Key words

Adrenomedullin - euglycemic hyperinsulinemic clamp

References

  • 1 Bonadonna R C, Groop L, Kramer N, Ferrannini E, Del Prato S, De Fronzo R A. Obesity and insulin resistance in humans: a dose-response study.  Metabolism. 1990;  39 452-459
    CrossrefPubMedGoogle Scholar
  • 2 Charles C J, Rademaker M T, Richards A M, Coeper G J, Coy D H, Jing N Y, Nicholls M G. Hemodynamic, hormonal and renal effects of adrenomedullin in conscious sheep.  Am J Physiol. 1997;  272 (6 Pt 2) R2040-2047
    PubMedGoogle Scholar
  • 3 DeFronzo R A, Tobin J D, Andres R. Glucose clamp tecnique: a method for quantifying insulin secretion resistance.  Am J Physiol. 1979;  237 E214-E222
    PubMedGoogle Scholar
  • 4 Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi E V. Adrenomedullin in pregnancy.  Lancet. 1997;  349 328-(letter)
    CrossrefPubMedGoogle Scholar
  • 5 Ebara T, Miura K, Okumura M, Matsuura T, Kimi S, Yukimura T, Iwao H. Effect of adrenomedullin on renal hemodynamics and functions in dogs.  Eur J Pharmacol. 1994;  263 69-73
    CrossrefPubMedGoogle Scholar
  • 6 Eto T, Kitamura K, Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases.  Clinical Exp Pharmacol Physiol. 1999;  26 371-380
    PubMedGoogle Scholar
  • 7 Fukuhara M, Tsuchiohashi T, Abe I, Fujishima M. Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits.  Am J Physiol. 1995;  269 R1289-1293
    PubMedGoogle Scholar
  • 8 Grey N, Kipnis D M. Effect of diet composition on the hyperinsulinemia of obesity.  N Engl J Med. 1971;  285 827-831
    PubMedGoogle Scholar
  • 9 Iacobellis G, Ribaudo M C, Leto G, Zappaterreno A, Vecci E, Di Mario U. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity.  Obes Res. 2002;  10 767-773
    PubMedGoogle Scholar
  • 10 Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma.  FEBS Lett. 1994;  338 6-10
    CrossrefPubMedGoogle Scholar
  • 11 Katsuki A, Sumida Y, Gabazza E C, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus.  Eur J Endocrinol. 2002;  147 71-75
    CrossrefPubMedGoogle Scholar
  • 12 Kitamura K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.  Biochem Biophys Res Commun. 1993;  192 553-560
    CrossrefPubMedGoogle Scholar
  • 13 Letizia C, Cerci S, Centanni M, De Toma G, Subioli S, Scuro L. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment.  Clin Endocrinol (Oxf). 1998;  48 145-148
    PubMedGoogle Scholar
  • 14 Letizia C, Tamburrano G, Alò P, Paoloni A, Caliumi C, Marinoni E. Adrenomedullin, a new peptide, in patients with insulinoma.  Eur J Endocrinol. 2001;  144 517-520
    CrossrefPubMedGoogle Scholar
  • 15 Lainchbury J G, Troughton R W, Lewis L K, Yandle T G, Richards A M, Nicholls M G. Hemodynamic, hormonal and renal effects of short-term adrenomedullin infusion in healthy volunteers.  J Clin Endocrinol Metab. 2000;  85 1016-1020
    CrossrefPubMedGoogle Scholar
  • 16 Majid D S, Kadowitz P J, Coy D H, Navar L G. Renal responses to intra-arterial administration of adrenomedullin in dogs.  Am J Physiol. 1996;  270 F200-F205
    PubMedGoogle Scholar
  • 17 Marinoni E, Di Iorio R, Letizia C, Villaccio B, Scucchi L, Cosmi E V. Immunoreactive adrenomedullin in human fetoplacental tissues.  Am J Obstet Gynecol. 1998;  178 784-787
    PubMedGoogle Scholar
  • 18 Martinez A, Weaver C, Lopez J, Bhathena S J, Elsasser T H, Miller M J, Moody T W, Unworth E J, Cutitta F. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin.  Endocrinology. 1996;  137 2626-2632
    CrossrefPubMedGoogle Scholar
  • 19 Martinez A, Cutitta F, Teitelman G. Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types.  Cell Tissue Res. 1998;  293 95-100
    CrossrefPubMedGoogle Scholar
  • 20 Messerli F H, Ventura H O, Reisin E, Dreslinski G R, Dunn F G, MacPhee A A, Frohlich E D. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output.  Circulation. 1982;  66 55-60
    PubMedGoogle Scholar
  • 21 Minami J, Nishikimi T, Ishimitsu T, Makino Y, Kawano Y, Takaishita S, Kangawa K, Matsuoka H. Effect of an hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension.  J Cardiovasc Pharmacol. 2000;  36 (Suppl 2) 583-586
    PubMedGoogle Scholar
  • 22 Nagai Y, Yamashita H, Takamura T, Kobayashi K I. Does acute hyperinsulinemia change plasma adrenomedullin concentration in healthy men?.  Diab Med. 2000;  17 249-250
    PubMedGoogle Scholar
  • 23 Nagaya N, Nishikimi T, Horio T, Yoshihara F, Kanazawa A, Matsuo H, Kangawa K. Cardiovascular and renal effects of adrenomedullin in rats with heart failure.  Am J Physiol. 1999;  276 R213-218
    PubMedGoogle Scholar
  • 24 Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparison between normal subjects and patients with chronic heart failure.  Circulation. 1997;  95 1214-1221
    PubMedGoogle Scholar
  • 25 Parkes D G. Cardiovascular actions of adrenomedullin in conscious sheep.  Am J Physiol. 1995;  268 H2574-H2578
    PubMedGoogle Scholar
  • 26 Rademaker M T, Charles C J, Lewis L K, Yandle T G, Cooper G J, Coy D H, Richards A M, Nicholls M G. Benefical hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.  Circulation. 1997;  96 1983-1990
    PubMedGoogle Scholar
  • 27 Raison J, Achimastos A, Asmar R, Simon A, Safar M. Extracellular and interstitial fluid volume in obesity with and without associated systemic hypertension.  Am J Cardiol. 1986;  57 223-226
    CrossrefPubMedGoogle Scholar
  • 28 Richards A M, Nicholls M G, Lewis L, Lainchbury J G. Adrenomedullin.  Clin Sci. 1996;  91 3-16
    PubMedGoogle Scholar
  • 29 Salans L, Knittle J, Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity.  J Clin Invest. 1968;  47 153-165
    PubMedGoogle Scholar
  • 30 Sato K, Hirata J, Irai T, Iwashina M, Marmo E. Characterization of immunoreactive adrenomedullin in human plasma and urine.  Life Sci. 1995;  57 189-194
    CrossrefPubMedGoogle Scholar
  • 31 Sowers J R, Whitfield L A, Catania R A, Stern N, Tuck M L, Dornfeld L, Maxwell M. Role of sympathetic nervous system in blood pressure maintenance in obesity.  J Clin Endocrinol Metab. 1982;  54 1181-1186
    PubMedGoogle Scholar
  • 32 Stern J, Batchelor B R, Hollander N, Cohn C K, Hirsch J. Adipose-cell size and immunoreactive insulin levels in obese and in normal-weight adults.  Lancet. 1972;  2 (7784) 948-951
    PubMedGoogle Scholar

Prof. M.D. Claudio Letizia

Dept. Scienze Cliniche
Policlinico Umberto I

Viale del Policlinico 155

00156 Roma

Italy

Phone: + 39649970650

Fax: + 39 6 49 97 05 24

Email: claudio.letizia@uniroma1.it

      >